161 related articles for article (PubMed ID: 10189274)
1. Link between drug absorption solubility and permeability measurements in Caco-2 cells.
Pade V; Stavchansky S
J Pharm Sci; 1998 Dec; 87(12):1604-7. PubMed ID: 10189274
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model.
Pade V; Stavchansky S
Pharm Res; 1997 Sep; 14(9):1210-5. PubMed ID: 9327450
[TBL] [Abstract][Full Text] [Related]
3. Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership.
Yang Y; Faustino PJ; Volpe DA; Ellison CD; Lyon RC; Yu LX
Mol Pharm; 2007; 4(4):608-14. PubMed ID: 17637014
[TBL] [Abstract][Full Text] [Related]
4. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
5. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
6. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
Fliszar KA; Hill BT; Foster N
J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
[TBL] [Abstract][Full Text] [Related]
7. The "high solubility" definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs.
Yazdanian M; Briggs K; Jankovsky C; Hawi A
Pharm Res; 2004 Feb; 21(2):293-9. PubMed ID: 15032311
[TBL] [Abstract][Full Text] [Related]
8. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.
Rinaki E; Valsami G; Macheras P
Pharm Res; 2003 Dec; 20(12):1917-25. PubMed ID: 14725354
[TBL] [Abstract][Full Text] [Related]
9. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.
Artursson P; Karlsson J
Biochem Biophys Res Commun; 1991 Mar; 175(3):880-5. PubMed ID: 1673839
[TBL] [Abstract][Full Text] [Related]
10. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.
Saha P; Kou JH
Eur J Pharm Biopharm; 2000 Nov; 50(3):403-11. PubMed ID: 11072198
[TBL] [Abstract][Full Text] [Related]
11. Simulation modelling of human intestinal absorption using Caco-2 permeability and kinetic solubility data for early drug discovery.
Thomas S; Brightman F; Gill H; Lee S; Pufong B
J Pharm Sci; 2008 Oct; 97(10):4557-74. PubMed ID: 18300298
[TBL] [Abstract][Full Text] [Related]
12. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
13. Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorption.
Yamashita S; Tanaka Y; Endoh Y; Taki Y; Sakane T; Nadai T; Sezaki H
Pharm Res; 1997 Apr; 14(4):486-91. PubMed ID: 9144736
[TBL] [Abstract][Full Text] [Related]
14. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach.
Sinko PJ; Leesman GD; Amidon GL
Pharm Res; 1991 Aug; 8(8):979-88. PubMed ID: 1924168
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption.
Rubas W; Jezyk N; Grass GM
Pharm Res; 1993 Jan; 10(1):113-8. PubMed ID: 8430047
[TBL] [Abstract][Full Text] [Related]
16. Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay.
Skolnik S; Lin X; Wang J; Chen XH; He T; Zhang B
J Pharm Sci; 2010 Jul; 99(7):3246-65. PubMed ID: 20166204
[TBL] [Abstract][Full Text] [Related]
17. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
[TBL] [Abstract][Full Text] [Related]
18. In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model.
Lozoya-Agullo I; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M
J Pharm Sci; 2015 Sep; 104(9):3136-45. PubMed ID: 25891783
[TBL] [Abstract][Full Text] [Related]
19. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
